INFO:

A major study led by BCRF investigator Dr. Fergus Couch is poised to change genetic testing, risk assessment, and personalized treatment for patients with BRCA2 mutations. These findings are especially important for people of color, who tend to have more variants of uncertain significance. Visit BCRF.org to read the full article and learn more about these practice-changing findings.